ICON is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives.
Our services can be implemented separately or as part of a comprehensive full service clinical programme that can help expedite the time it takes to bring a drug to market and monitor its performance and safety post approval.
Share Price NASDAQ
Data Provided by Refinitiv. Minimum 15 minutes delayed.